Improving executive function in children with autism in South Korea
A Randomized, Control Trial of Executive Function Training for Korean Kindergartners With Autism Spectrum Disorder
NA · Korea University · NCT06523660
This study is testing a new training program to help improve thinking and planning skills in young children with autism in South Korea.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 5 Years to 7 Years |
| Sex | All |
| Sponsor | Korea University (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06523660 on ClinicalTrials.gov |
What this trial studies
This randomized controlled study aims to evaluate the acceptability, feasibility, and preliminary efficacy of an executive function (EF) training intervention for children aged 5 to 7 with autism spectrum disorder (ASD) in South Korea. The study will assess the intervention's effectiveness using multimodal methods, including lab-based behavioral tasks and electrophysiological measures, while also examining the generalization of skills to everyday settings through parent ratings. With limited intervention services available during critical school transition periods, this research seeks to fill a significant gap in support for young children with ASD.
Who should consider this trial
Good fit: Ideal candidates for this study are Korean children aged 5 to 7 with a confirmed diagnosis of autism spectrum disorder and a non-verbal IQ of 85 or above.
Not a fit: Patients with a non-verbal IQ below 85 or those with significant sensory or motor impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance executive function skills in autistic children, leading to improved social and academic outcomes.
How similar studies have performed: While few studies have investigated EF interventions in ASD, the need for evidence-based approaches suggests that this study could provide valuable insights into a relatively novel area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Previous medical diagnosis of ASD, confirmed by Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) * Non-verbal IQ (NVIQ) equal to or above 85 * Verbal children (with flexible phrases or complex sentences) Exclusion Criteria: * NVIQ below 85 * Presence of medical disorders or injuries with implications for the central nervous system or that require medications that alter EEG processes such as anticonvulsants * Presence of significant sensory or motor impairment * Presence of major physical anomalies
Where this trial is running
Seoul
- Korea University — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Principal investigator: So Hyun Kim, PhD — Korea University
- Study coordinator: So Hyun Kim, PhD
- Email: sohkim@korea.ac.kr
- Phone: 02-3290-2065
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Autism Spectrum Disorder